Effects of duodenal seal oil administration in patients with inflammatory bowel disease

Lipids

Volumn 37, Issue 10, 2002, Pages 935-940

  Arslan, Gülen ^a   Brunborg, Linn Anne ^a   Frøyland, Livar ^a   Brun, Johan G ^a   Valen, Merete ^a   Berstad, Arnold ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; BLOOD; CHOLESTEROL; DISEASES; MEDICAL APPLICATIONS; OILS AND FATS; PATIENT TREATMENT;

INFLAMMATORY RESPONSES;

LIPIDS;

CALPROTECTIN; OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ARTHRALGIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DUODENUM; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE LAVAGE; INTESTINE MUCOSA PERMEABILITY; LIPID PEROXIDATION; MALE; PAIN ASSESSMENT; SEAL; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ANIMALS; ARTHRALGIA; CHRONIC DISEASE; COLITIS; CROHN DISEASE; DUODENUM; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LONGITUDINAL STUDIES; MALE; OILS; SEALS, EARLESS;

PHOCIDAE;

EID: 0345772129     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-006-0983-2     Document Type: Article

References (35)

1. O'Morain, C., Tobin, A., Suzuki, Y., McColl, T., and Collins, R. (1990) Fish oil in the treatment of ulcerative colitis, Scand. J. Gastroenterol. 31, 267-272.
2. Drevon, C. (1992) Marine oils and their effects, Nutr. Rev. 50, 159-163.
3. Nordøy, A. (1991) Is there a rational use for n-3 fatty acids (fish oils) in clinical medicine? Drugs 42, 331-342.
4. Akiba, S., Murata, T., Kitatani, K., and Sato, T. (2000) Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation, Biol. Pharm. Bull. 23, 1293-1297.
5. Shahidi, F., and Synowiecki, J. (1992) Seal meat: A unique source of muscle for health and nutrition, Food Rev. Int. 12, 283-302.
6. Harvey, R., and Bradshaw, J. (1980) A simple index of Crohn's disease activity, Lancet 1, 514.
7. Walmsley, R., Ayres, R., and Allan, R. (1998) A simple clinical colitis activity index, Gut 43, 29-32.
8. Fries, J.F., Spitz, P., Kraines, R.G., and Holman, H.R. (1980) Measurement of patient outcome in arthritis, Arthritis Rheum. 23, 137-145.
9. Fuchs, H.A., and Pincus, T. (1994) Reduced joint counts in controlled clinical trials in rheumatoid arthritis, Arthritis Rheum. 37, 470-475.
10. Schmedes, A., and Holmer, G. (1989) A new thiobarbituric acid (TBA) method for determining free malondialdehyde (MDA) and hydroperoxides selectively as a measure of lipid peroxidation, J. Am. Oil Chem. Soc. 66, 813-817.
11. Handy, M.L., Ghosh, S., and Ferguson, A. (1995) Investigation of neutrophil migration into the gut by cytology of whole gut lavage fluid, Eur. J. Gastroenterol. Hepatol. 7, 53-58.
12. Acciuffi, S., Ghosh, S., and Ferguson, A. (1996) Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss, Aliment. Pharmacol. Ther. 10, 321-326.
13. 51Cr EDTA in inflammatory bowel disease, Gastroenterology 85, 18-22.
14. Bjarnason, I., Macpherson, A., and Hollander, D. (1995) Intestinal permeability: An overview, Gastroenterology 108, 1566-1581.
15. Lie, Ø., and Lambertsen, G. (1991) Fatty acid composition of glycerophospholipids in seven tissues of cod (Gadus morhua), determined by combined high-performance liquid chromatography and gas chromatography, J. Chromatogr. 565, 119-129.
16. Berstad, A., Arslan, G., and Folvik, G. (2000) Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid, Scand. J. Gastroenterol. 35, 64-69.
17. Lorenz, R., Weber, P.C., Szimnau, P., Heldwein, W., Strasser, T., and Loeschke, K. (1989) Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease - A randomized, placebo-controlled, double-blind cross-over trial, J. Int. Med. 225 (Suppl. 1), 225-232.
18. McCall, T.B., O'Leary, D., Bloomfield, J., and O'Morain, C.A. (1989) Therapeutic potential of fish oil in the treatment of ulcerative colitis, Aliment. Pharmacol. Ther. 3, 415-424.
19. Stenson, W.F., Cort, D.C., Rodgers, J., Burakoff, R., DeSchryver-Kecskemeti, K., Gramlich, T.L., and Beeken, W. (1992) Dietary supplementation with fish oil in ulcerative colitis, Ann. Int. Med. 116, 609-614.
20. Aslan, A., and Triadafilopoulos, G. (1992) Fish oil fatty acid supplementation in active ulcerative colitis: A double-blind, placebo-controlled, crossover study, Am. J. Gastroenterol. 87, 432-437.
21. Hawthorne, A.B., Daneshmend, T.K., Hawkey, C.J., Belluzzi, A., Everitt, S.J., Holmes, G.K.T., Malkinson, C., Shaheen, M.Z., and Willars, J.E. (1992) Treatment of ulcerative colitis with fish oil supplementation: A prospective 12-month randomised controlled trial, Gut 33, 922-928.
22. Belluzzi, A., Brignola, C., Campieri, M., Pera, A., Boschi, S., and Migiolo, M. (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease, N. Engl. J. Med. 334, 1557-1560.
23. Lorenz-Meyer, H., Nicolay, C., and Schulz, B. (1996) Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease: A randomised controlled multicentre trial, Scand. J. Gastroenterol. 31, 778-785.
24. Ackman, R.G. (1988) Some possible effects on lipid biochemistry of differences in the distribution on glycerol of long-chain n-3 fatty acids in the fats of marine fish and marine mammals, Atherosclerosis 70, 171-173.
25. Hillier, K., Jewell, R., Dorrel, L., and Smith, L. (1991) Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease, Gut 32, 1151-1155.
26. Belluzzi, A., Brignola, C., Campieri, M., Camporesi, E., Gionchetti, P., and Rizzello, F. (1994) Effects of new fish oil derivative and fatty acid phospholipid membrane pattern in a group of Crohn's disease patients, Dig. Dis. Sci. 39, 2589-2594.
27. Yoshida, H., Kummaru, J., Mawatari, M., Ikeda, I., Imaizumi, K., and Tsuji, H. (1996) Lymphatic absorption of seal and fish oils and their effect on lipid metabolism and eicosanoid production in rats, Biosci. Biotechnol. Biochem. 60, 1293-1298.
28. Ikeda, I., Yoshida, H., Tomooka, M., Yosef, A., Imaizumi, K., and Tsuji, H. (1998) Effects of long-term feeding of marine oils with different positional distribution of eicosapentaenoic and docosahexaenoic acids on lipid metabolism, eicosanoid production, and platelet aggregation in hypercholesterolemic rats, Lipids 33, 897-904.
29. Girelli, D., Olivieri, O., and Stanzial, A.M. (1994) Factors affecting the thiobarbituric acid test as index of red blood cell susceptibility to lipid peroxidation: A multivariate analysis, Clin. Chim. Acta 227, 45-57.
30. Harris, W. (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review, J. Lipid Res. 30, 785-807.
31. Kremer, J.M., Jubiz, W., Michalek, A., Rynes, R., Bartholomew, L.E., and Bigaouette, J. (1987) Fish oil fatty acid supplementation in active rheumatoid arthritis, Ann. Intern. Med. 106, 497-503.
32. Kremer, J.M., Lawrence, D.A., Jubiz, W., Digiacomo, R., Rynes, R., Bartholomew, L.E., and Sherman, M. (1990) Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis, Arthritis Rheum. 33, 810-820.
33. Volker, D., Fitzgerald, P., Major, G., and Garg, M. (2000) Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis, J. Rheumatol. 27, 2343-2346.
34. Gravallese, E.M., and Kantrowitz, F.G. (1988) Arthritic manifestations of inflammatory bowel disease, Am. J. Gastroenterol. 83, 703-709.
35. Florin, T.H.J., Graffner, H., Nilsson, L.G., and Persson, T. (2000) Treatment of joint pain in Crohn's patients with budesonide-controlled ileal release, Clin. Exp. Pharmacol. Physiol. 27, 295-298.